Regulatory · source year

2010 regulatory records

8 selected, source-linked regulatory records dated 2010. This is selective source coverage, not a complete timeline.

Dated records

8 selected records.

Peptide profiles

6 connected profiles.

Cited sources

8 distinct public records.

Cited chronology

Dated source records

All record types in 2010 →

December 2010

1 record

Bivalirudin

Federal Register notice 2010-31583

The Federal Register published notice 2010-31583, attributed to FDA and its parent HHS department, on 2010-12-16. Its official title is “Determination of Regulatory Review Period for Purposes of Patent Extension; ANGIOMAX,” and PeptideScanner's exact reviewed identity mapping connects the document to Bivalirudin.

Source: Federal Register via GovInfo ↗

→

November 2010

1 record

May 2010

1 record

Desmopressin

Federal Register notice 2010-11038

The Federal Register published notice 2010-11038, attributed to FDA and its parent HHS department, on 2010-05-11. Its official title is “Pediatric Advisory Committee; Notice of Meeting,” and PeptideScanner's exact reviewed identity mapping connects the document to Desmopressin.

Source: Federal Register via GovInfo ↗

→

March 2010

3 records

Tesamorelin

Federal Register notice 2010-6169

The Federal Register published notice 2010-6169, attributed to FDA and its parent HHS department, on 2010-03-22. Its official title is “Endocrinologic and Metabolic Drugs Advisory Committee; Notice of Meeting,” and PeptideScanner's exact reviewed identity mapping connects the document to Tesamorelin.

Source: Federal Register via GovInfo ↗

→

Degarelix

Federal Register notice 2010-4159

The Federal Register published notice 2010-4159, attributed to FDA and its parent HHS department, on 2010-03-01. Its official title is “Determination of Regulatory Review Period for Purposes of Patent Extension; FIRMAGON,” and PeptideScanner's exact reviewed identity mapping connects the document to Degarelix.

Source: Federal Register via GovInfo ↗

→

January 2010

2 records

Tesamorelin

Federal Register notice 2010-785

The Federal Register published notice 2010-785, attributed to FDA and its parent HHS department, on 2010-01-19. Its official title is “Endocrinologic and Metabolic Drugs Advisory Committee; Notice of Meeting,” and PeptideScanner's exact reviewed identity mapping connects the document to Tesamorelin.

Source: Federal Register via GovInfo ↗

→